Connection

TETSUO ASHIZAWA to Antibody Formation

This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Antibody Formation.
Connection Strength

0.047
  1. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc Natl Acad Sci U S A. 1992 Jul 01; 89(13):5852-6.
    View in: PubMed
    Score: 0.024
  2. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
    View in: PubMed
    Score: 0.012
  3. Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. J Neuroimmunol. 2000 Jun 26; 105(2):131-44.
    View in: PubMed
    Score: 0.010
  4. Antigenic determinants of hen egg-white lysozyme in delayed hypersensitivity. II. Antigenicity and immunogenicity of the N- and C-terminal peptide. Biken J. 1975 Dec; 18(4):229-47.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.